Should PNPLA3 polymorphism be performed in clinical practice in patients with NAFLD to predict the risk of disease progression?
Hepatology
.
2022 Nov;76(5):1246-1247.
doi: 10.1002/hep.32510.
Epub 2022 Apr 19.
Author
Claudia P Oliveira
1
Affiliation
1
Department of Gastroenterology, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
PMID:
35384002
DOI:
10.1002/hep.32510
No abstract available
Publication types
Editorial
Comment
MeSH terms
Disease Progression
Genetic Predisposition to Disease
Genotype
Humans
Lipase / genetics
Non-alcoholic Fatty Liver Disease* / genetics
Polymorphism, Genetic
Polymorphism, Single Nucleotide
Substances
Lipase